Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.729608
Title: Elucidating the role of ADAM33 in airway inflammation and remodelling in asthma
Author: Davies, Elizabeth R.
Awarding Body: University of Southampton
Current Institution: University of Southampton
Date of Award: 2014
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Asthma is a heterogeneous chronic inflammatory disease characterised by recurrent, reversible airflow obstruction, bronchial hyperresponsiveness (BHR) and airway remodelling. Impaired lung function in childhood asthma has been associated with polymorphisms in ADAM33. Soluble ADAM33 (sADAM33) is increased in bronchial lavage fluid (BALF) from asthmatics and is inversely correlated with FEV1. sADAM33 is induced by TGF-β present in asthmatic lungs, and promotes angiogenesis. ADAM33 expression is developmentally regulated and is influenced by maternal allergy via IL-13. This thesis will examine the hypothesis that alteration in the expression of ADAM33 will influence lung structure, affecting vessel and smooth muscle formation and these subsequent changes will impact on pulmonary function in airway inflammation. In DOX inducible Il-13 transgenic mice, significant neutrophilic inflammation and goblet cell metaplasia were observed. BHR was induced after methacholine challenge and IHC showed increased bronchial smooth muscle. Similarly, in human embryonic and juvenile mouse lungs, IL-13 suppressed Adam33 mRNA but not Acta2. ADAM33 was identified in BALF of the overexpressing mice. ADAM33 enzymatic activity was also significantly increased. In the ADAM33 transgenic model, induction of ADAM33 resulted in enzymatically active sADAM33 in BALF. ADAM33 significantly increased the expression of fibrotic markers suggesting regulation of pulmonary myogenesis, fibrogenesis, and angiogenesis. Consistent with this, immunofluorescence revealed airway remodelling with increased smooth muscle, collagen deposition and vessel formation in ADAM33 mice. In contrast, inflammatory cell counts in BALF, expression of inflammatory mediators and mucus related genes were not altered by ADAM33. In Adam33 -/- challenged with HDM, there was less BHR and eosinophilic and neutrophilic inflammation compared to Adam33 +/+. HDM caused suppression of Adam33 mRNA as well as ectodomain shedding of ADAM33 protein in BALF of wildtype mice that was absent in Adam33 -/-. The study provides novel data showing expression of sADAM33 in airways to induce myogenesis, fibrogenesis and angiogenesis, consistent with a process causing airway remodelling in the absence of inflammation.
Supervisor: Haitchi, Hans Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.729608  DOI: Not available
Share: